Login / Signup

Impact of the COVID-19 pandemic on pathological autopsy practices in Japan.

Yuichiro HirataShun IidaTakeshi ArashiroSayaka NagasawaHisako SaitohHiroyuki AbeMasako IkemuraYohsuke MakinoRintaro SawaHirotaro IwaseTetsuo UshikuTadaki SuzukiShinji Akitomi
Published in: Pathology international (2023)
During the coronavirus disease 2019 (COVID-19) pandemic, autopsies have provided valuable insights into the pathogenesis of COVID-19. The precise effect of this pandemic on autopsy procedures in Japan, especially in instances unrelated to COVID-19, has not yet been established. Therefore, we conducted a questionnaire survey from December 2020 to January 2021 regarding the status of pathological autopsy practices in Japan during the first year of the COVID-19 pandemic. The questionnaire was sent to 678 medical facilities with pathologists, of which 227 responded. In cases where a confirmed diagnosis of COVID-19 was not made at the time of autopsy, many facilities counted them as suspected COVID-19 cases if pneumonia was suspected clinically. At around half of the sites, autopsies were prohibited for suspected COVID-19 cases. In addition, the number of autopsies of non-COVID-19 cases during the pandemic period was also investigated, and a significant decrease was observed compared with the incidence in the pre-pandemic period. The COVID-19 pandemic has affected not only the autopsies of COVID-19 cases but also the entire practice of pathological autopsies. It is necessary to establish a system that supports the implementation of pathological autopsy practices during the pandemic of an emerging infectious disease.
Keyphrases
  • coronavirus disease
  • sars cov
  • healthcare
  • primary care
  • respiratory syndrome coronavirus
  • pulmonary embolism
  • cross sectional
  • risk factors
  • extracorporeal membrane oxygenation